Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Comprehensive Laboratory & Specimen Collection Services

Active
IC-RFP-2026-003State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Integral Care is seeking a qualified laboratory services provider to deliver comprehensive clinical laboratory testing and on-site specimen collection services that directly support the delivery of behavioral health care across Texas. The vendor will be responsible for providing timely, accurate, and reliable diagnostic testing essential for patient evaluation, medication management, crisis stabilization, and ongoing treatment, with a focus on high-volume tests including Complete Blood Counts, Hemoglobin A1C, lipid panels, comprehensive metabolic panels, thyroid function tests, therapeutic drug monitoring for psychotropic medications, urine toxicology screens, and infectious disease screening for HIV, Hepatitis, and STIs. Services must also include metabolic and endocrine monitoring, hematology testing, TB screening, and drug testing for substance use treatment programs, ensuring alignment with the clinical needs of individuals receiving community-based behavioral health services. The selected provider must demonstrate proven capacity to handle high-volume testing with consistent turnaround times while maintaining flexibility for stat or rapid testing when clinically necessary. On-site specimen collection services are required to ensure accessibility for clients across Integral Care’s programs, and proposers must detail their operational capabilities, including technology systems, quality control measures, and logistics for timely sample handling and reporting. All services must support the organization’s mission to expand access, improve outcomes, and promote patient stabilization. Proposals are due by September 30, 2026, and inquiries should be directed to Christina Lundy at Integral Care in Texas.

General Info

Provider to deliver high-volume clinical lab testing and on-site specimen collection for behavioral health services across Texas.

Agency

Texas → Integral CareView Agency

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

TX, USA

Set-Aside

NONE

Documents

(2)

ATTACHMENT D - Lab and Specimen.xlsx

XLSX

IC-RFP-2026-003 - Lab and Specimen.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyTexas → Integral Care
Contacts1 person available
OfficeTX, USA
Organization / Agency
Texas → Integral Care
View Agency Profile
Office AddressTX, USA
Contacts
Christina Lundy
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
Integral Care seeks a qualified laboratory services provider to deliver comprehensive clinical laboratory testing and on‑site specimen collection services that support Integral Care’s mission to expand access to care, improve client outcomes, and promote stabilization for individuals receiving behavioral health services across the community, as more particularly described in this RFP (collectively, the “Services”). The selected vendor will provide timely, reliable laboratory testing that supports diagnostic evaluation, medication management, crisis stabilization, and ongoing treatment across all Integral Care programs. Required laboratory services include, but are not limited to: · Routine blood panels and general laboratory diagnostics · Medication monitoring related to psychotropic medications · Metabolic monitoring · Hematology testing · Endocrine screening · Infectious disease testing · Urine testing and urinalysis · Toxicology screening · Drug testing for substance use treatment programs · Sexually transmitted infection (STI) testing · HIV and Hepatitis screening · Tuberculosis (TB) testing · Other laboratory diagnostics necessary to support behavioral health treatment and clinical decision‑making Based on historical testing data, the most frequently ordered laboratory tests include: · Complete Blood Count (CBC) · Hemoglobin A1C testing · Lipid panels · Comprehensive metabolic panels (CMP) · Thyroid testing (TSH/Free T4) · Therapeutic drug monitoring (Lithium, Valproic Acid, Clozapine) · Urine toxicology screening panels · Infectious disease screening (HIV, Hepatitis) Proposers (defined below) should demonstrate strong operational capability supporting these high-volume tests. Integral Care seeks laboratory services that support routine testing turnaround times and offer flexibility for expedited processing when clinically indicated. Proposers should describe available stat, rapid, or other expedited testing options and associated turnaround times, if applicable

Similar Contracts

Same NAICS industry code

NAICS: 621511
New
Federal
Funding for New Contract for OST/AOCC Full- Service Covid-19 Testing Service (C-19TS) Based on the Polymerase Chain Reaction (PCR) Testing Process, IDIQ with a 5 year ordering periodThe National Nuclear Security Administration under the Department of Energy is forecasting a new Indefinite Delivery Indefinite Quantity (IDIQ) contract for comprehensive COVID-19 testing services based on the Polymerase Chain Reaction (PCR) process. This contract, titled Funding for New Contract for OST/AOCC Full-Service COVID-19 Testing Service (C-19TS), has a five-year ordering period and is intended to support ongoing testing needs through a full-service provider capable of end-to-end PCR testing operations. The acquisition is designated as a small business set-aside, aiming to prioritize participation from small businesses in the bidding and performance process. The NAICS code 621511 identifies the scope as Laboratory Services, specifically clinical diagnostic labs, indicating the work involves specimen collection, lab analysis, reporting, and related support for COVID-19 testing. The point of contact for small business inquiries is Chelsea Murphy, Small Business Program Manager, reachable via email. Although the solicitation number and specific place of performance are not yet defined, the posting date indicates this is a forward-looking forecast, with the actual procurement expected to follow in the near future.
National Nuclear Security Administration

POSTED

about 15 hours ago

DEADLINE

N/A
View Details
NAICS: 621511
New
SLED
Full Panel Clinical Laboratory Services (All Listed Tests)
DAS Procurement

POSTED

about 22 hours ago

DEADLINE

in 20 days
View Details
NAICS: 621511
New
SLED
Basic Metabolic Panel (BMP) Testing Services
DAS Procurement

POSTED

about 22 hours ago

DEADLINE

in 20 days
View Details
NAICS: 621511
New
SLED
Comprehensive Metabolic Panel (CMP) Testing Services
DAS Procurement

POSTED

about 22 hours ago

DEADLINE

in 20 days
View Details
NAICS: 621511
New
SLED
Clinical Laboratory Services for The Nathaniel Witherell
Solicitation # 7967
The Town of Greenwich is soliciting clinical laboratory services for The Nathaniel Witherell, a skilled nursing facility located in Greenwich, Connecticut, under solicitation number 7967. The contract requires a provider to deliver comprehensive laboratory testing services, including phlebotomy and routine and STAT specimen transport, Monday through Friday for standard tests and seven days a week for urgent requests with a maximum four-hour response time. Services must include test requisitions, reference ranges, a dedicated reporting printer, infection control reports, quarterly utilization data, staff education, and 24/7 access to test results via secure internet, with critical values communicated within 60 minutes. The contractor must be licensed by the State of Connecticut, certified under CLIA, accredited by the College of American Pathologists, and fully compliant with HIPAA, HITECH, OSHA Universal Precautions, and accessibility standards under 28 CFR § 35.200. Performance will occur entirely within Greenwich, CT, with all services delivered at The Nathaniel Witherell, and transportation costs are included under FOB destination inside delivery terms. Proposals must be submitted in hard copy—one original and four copies—along with a single flash drive, and must include an executed letter of transmittal, an Insurance Procedure Form, and a Statement of Proposing Company’s Qualifications. Bids are not accepted electronically and must be received by 11:00 AM on August 31, 2026, at the Greenwich Purchasing Department. The evaluation will be based on a trade-off process awarding up to 100 points across five factors: firm’s experience with skilled nursing facilities (30 points), staff expertise (30 points), competitive advantages (20 points), proposal quality (10 points), and operational capability (10 points). No lowest price technically acceptable (LPTA) method will be used. Contractual obligations include strict insurance requirements of $1 million per occurrence for general and auto liability, statutory workers’ compensation, and employer’s liability coverage, with insurers rated A- VII or higher by AM Best and the Town named as an additional insured. The contract prohibits assignment without approval, mandates indemnification in favor of the Town, and binds all parties under Connecticut law, with disputes to be resolved exclusively in the Stamford/Norwalk Superior Court. The agreement is a fixed-price personal services contract with optional years, but no pricing is currently specified in the line items, and no federal FAR clauses apply
DAS Procurement

POSTED

about 22 hours ago

DEADLINE

in 20 days
View Details
NAICS: 621511
New
Federal
Specialty Neuroimmunology Reference Laboratory Services
261-NETWORK Contract Office 21 (36C261)

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 621511
New
Federal
GAD65 Antibody Testing (CSF)
261-NETWORK Contract Office 21 (36C261)

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 621511
New
Federal
Autoimmune Epilepsy Antibody Testing
261-NETWORK Contract Office 21 (36C261)

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 621511
New
Federal
Autoimmune Encephalopathy Testing (CSF)
261-NETWORK Contract Office 21 (36C261)

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 621511
New
Federal
Q301--Specialized Laboratory Testing, VA Palo Alto Health Care System
Solicitation # 36C26126Q1110
The Department of Veterans Affairs, through its Network Contracting Office 21, is seeking information from contractors capable of providing specialized laboratory testing services for the VA Palo Alto Health Care System under NAICS code 621511, which has a small business size standard of $41.5 million. This is a sources sought announcement only, not a solicitation, and no obligations or payments are incurred by the government for responses. All submitted information will be used internally to inform potential procurement strategy and is not binding. Responses must be submitted by email to Angela Gerlitzki no later than 10:00 a.m. EST on August 17, 2026, and must include the company’s legal name and SAM Unique Entity Identifier, socioeconomic status including SDVOSB or VOSB certification status verified on the SBA database, a capabilities statement, similar project history, copy of certifications, anticipated teaming or subcontracting plans demonstrating compliance with limitations on subcontracting, GSA contract number if applicable, and a completed price estimate on the attached schedule. Contractors must have an active SAM registration at the time of submission. The anticipated period of performance for any resulting contract would be October 1, 2026, through September 30, 2027. Failure to provide all requested information will render a submission non-responsive. The solicitation number 36C26126Q1110 must be referenced in all correspondence.
261-NETWORK Contract Office 21 (36C261)

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 621511
New
Federal
Q301--Cytopathology and Next Generation Sequencing Testing
Solicitation # 36C24226Q0875
The Department of Veterans Affairs Network Contracting Office 2 is seeking to establish a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract to provide comprehensive molecular diagnostic testing using next-generation sequencing (NGS) for thyroid nodules with indeterminate fine-needle aspiration cytology. The primary objective is to improve diagnostic accuracy, reduce unnecessary surgical interventions, and enable timely clinical decision-making for veterans at the Northport VA Medical Center. The contract will cover both cytopathology evaluation and molecular diagnostic testing services, with a five-year ordering period from October 1, 2026, through September 30, 2031. The government has set a minimum volume of 30 tests and a maximum of 600 tests over the contract term. The contractor must furnish all labor, materials, equipment, collection and shipping kits, courier services, and clinical reporting, ensuring compatibility with standard FNA prep methods and minimal specimen requirements. Testing must be clinically validated, capable of detecting SNVs, indels, fusions, CNAs, and gene expression patterns, and deliver actionable risk stratification for Bethesda III-V nodules with clear malignancy estimates. All proposals must come from entities registered and active in the System for Award Management (SAM), with a valid Unique Entity Identifier and, where applicable, an Electronic Funds Transfer indicator. Offers are evaluated based on Technical Capability, Past Performance, Key Personnel, Quality Management, and Price, with Technical and Past Performance collectively carrying more weight than price. Technical evaluation focuses on diagnostic performance metrics, validated NGS methodology, clinical utility, and experience with similar testing volumes. Quality management requires current CLIA certification and CAP accreditation, along with proficiency testing and robust QA procedures. Key personnel must include a board-certified molecular pathologist and qualified staff for high-complexity testing, with resumes and verified employment commitments submitted with the quote. Evaluation credit is available for Service-Disabled Veteran-Owned Small Businesses and Veteran-Owned Small Businesses verified in the VIP database, though the contract is not set aside for small businesses. The contractor must comply with all applicable FAR clauses modified by deviations through FAC 2026-01, including labor standards, equal opportunity, trafficking prevention, employment verification, and paid sick leave requirements. Security protocols require personal identity verification of contractor personnel, and payment must be processed via EFT through SAM. Proposals are due by 5:00 PM EST on August 21, 2026, and must be submitted electronically to
242-NETWORK Contract Office 02 (36C242)

POSTED

1 day ago

DEADLINE

in 10 days
View Details
NAICS: 621511
New
SLED
Clinical Laboratory Testing and Analysis
KY Dept of Veterans Affairs

POSTED

1 day ago

DEADLINE

in 14 days
View Details

More opportunities from Texas → Integral Care

Same awarding agency

NAICS: 456110
SLED
Contracted Pharmacy Services
Solicitation # IC-RFI-2026-008
Integral Care, based in Texas, is seeking qualified pharmacy providers to transition its current in-house Class A closed-door community pharmacy into a fully contracted operation while maintaining service within its existing facility. The pharmacy currently dispenses approximately 40 prescriptions daily, primarily serving Integral Care’s client population, and the agency aims to outsource operational responsibilities to reduce direct management burden and improve financial predictability. The goal is to enhance billing efficiency, maximize reimbursement rates, and stabilize or lower operating costs without compromising timely access to medications or continuity of care for clients. Interested vendors are invited to provide detailed insights on viable operating models, including licensure requirements, staffing structures, technology integration, billing systems, and implementation timelines that ensure seamless service transitions. All proposals must demonstrate a clear understanding of the unique needs of a behavioral health-focused pharmacy, the regulatory environment in Texas, and strategies for sustaining reliable medication access under a contracted model. Responses are due by August 14, 2026, with inquiries directed to Christina Lundy at Integral Care.
Pharmacies and Drug Retailers

POSTED

8 days ago

DEADLINE

in 3 days
View Details